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A B S T R A C T   
Background: Various studies have assessed the effectiveness of clinical pathways (CPs) in inpatient settings and 
provided systematic evidence that they positively affect patient outcomes and efficiency of care, thus lowering 
costs. In recent years, CP implementation is often combined or extended with clinical pathway software (CPS). 
Until now, no systematic literature review appears to exist which synthesizes the evidence on the effectiveness of 
CPS in inpatient settings, in relation to the CPs they support. 
Objectives: The purpose of this study was to systematically review evidence on (perceived) effectiveness of clinical 
pathway software (CPS) and investigate mechanisms explaining the effects of CPS implementation on outcomes. 
Methods: We searched MEDLINE via PubMed and Scopus, for English-language original articles. Articles were 
included if they examined the effectiveness and/or the perceived effectiveness of CPS in the inpatient setting. 
They were analyzed for evidence on structure, process and outcome effects, as well as for mechanisms explaining 
such effects in relation to contextual factors. 
Results: From 2904 articles, 12 studies met our inclusion criteria. The seven studies reporting on adherence 
provide conclusive evidence that CPSs can improve adherence. We also found conclusive evidence of 
improvement of process related measures regarding appropriate diagnostics, timeliness of care, and length of 
stay (LOS). Evidence on costs and outcomes is weak and/or less conclusive. This holds true both for patient 
outcomes (e.g. mortality/patient satisfaction) and caregiver outcomes (e.g. user satisfaction). The studies pre-
sented no direct evidence on mechanisms explaining how CPS relate to process and outcome improvements. 
Conclusions: The primary effects of CPS to increase adherence may in turn positively impact other process in-
dicators such as LOS, timeliness of care, and diagnostic effectiveness. Subsequent effects on costs, outcomes for 
patients, physicians and nurses remain inconclusive and call for further research. Further research should 
explicitly take context into account. The scarce and weak evidence-base relating CPS implementation to process 
and outcome effects needs development along the same lines.   
1. Introduction 
Worldwide, healthcare providers seek to ensure safety, effectiveness 
and efficiency of care [1]. Many instruments and technologies have been 
developed to this purpose [2–4]. Clinical pathways form one of these 
tools. A clinical pathway is ‘a complex intervention for the mutual de-
cision making and organisation of care processes for a well-defined 
group of patients during a well-defined period’ [5]. It defines essential 
steps in the care plan that a patient with a specific medical condition can 
undertake [6]. Clinical pathways have been implemented in hospitals 
across the globe [7,8]. Various studies provide evidence that clinical 
pathways positively affect patient outcomes and efficiency of care, thus 
lowering costs [7,9,10]. According to the systematic review conducted 
by Allen et al. [11], clinical pathways can beneficially impact timeliness 
of clinical interventions, standardization of guidelines, documentation 
of care, inter- and intra-professional consensus, and variance of care. 
Clinical pathways can be either paper- or software-based [12]. The 
paper-based method typically relies on manuals and forms on paper 
sheets, in addition to the patient records being kept [13]. Consequently, 
paper-based clinical pathways can result in more paperwork instead of 
simplifying daily routines for hospital staff, eventually hampering 
adherence and impact on effectiveness and efficiency of care [14,15]. As 
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a remedy to such shortcomings, and as a natural development in the 
progression of Health IT, clinical pathway software has been developed 
to support clinical pathways and promote their benefits [16,17]. 
While the effects of clinical pathways in inpatient settings have been 
thoroughly reviewed [7] this is not the case for clinical pathway soft-
ware. Recent reviews have addressed more general topics such as de-
cision support systems for inpatients [18,19] and health information 
technology to support clinical pathways [20]. Thus, the evidence base 
on clinical pathway software effectiveness for inpatient care presently 
consists of a variety of results from case studies in different settings [16, 
20–22]. Moreover, there is little understanding of the corresponding 
mechanisms that explain (lack of) effectiveness of clinical pathway 
software implementation. The purpose of this review is therefore to 
systematically synthesize the (perceived) effectiveness of clinical 
pathway software in inpatient settings and the underlying mechanisms. 
2. Methods 
2.1. Data sources and search query 
Studies were identified by systematically searching MEDLINE (via 
Scopus and Pubmed) by using the following search query: (Critical OR 
clinical OR collaborative OR care OR integrated) AND (pathway*) AND 
(software OR app*) AND (inpatient OR hospital), and from the studies 
included in the review of the closely related review by Neame et. al. 
[20]. 
2.2. Study selection and data extraction 
For quality purposes, we only included peer reviewed international 
(English) journal articles as identified by the data sources and query 
above, published between January 2000 and January 2018. The review 
by Neame et al. [20] had a wider search focus and additionally searched 
Embase. 
Further selection consisted of two rounds. In the first round, the 
search results were critically examined by reading the title and abstract, 
using the criteria depicted in Table 1. The full texts of the remaining 
studies were examined in the second round using the same exclusion 
criteria from Table 1. To further reduce the likelihood of missing rele-
vant peer reviewed literature, the references of the included articles 
were screened to identify additional candidate articles (snowballing). 
The conducted systematic search, inclusion of articles from a recent 
review with a broader scope, and the snowballing, together with the 
peer review requirement reduce risks of not including relevant publi-
cations and of including publications which fall short of scientific 
standards. Consensus was reached in case of doubt by consulting a third 
author. Inter-rater agreement was measured by Cohen’s kappa to 
determine the extent of agreement between two reviewers [23]. 
Using a structured extraction form, study characteristics (such as 
author, year, type of study, setting, number of patients, outcomes, and 
objectives) were extracted. Moreover, we collected data on the 
mechanisms explaining the results, to synthesis how clinical pathway 
software (henceforth also referred to as CPS) interacts with the clinical 
pathways (henceforth also CPs). An Excel file with all extracted data is 
available as an online Appendix. 
2.3. Data extraction, analysis and synthesis 
To gain a first understanding of the effectiveness of CPS, the results 
and conclusions of the included articles were evaluated. The studies 
were categorized by objectives and primary outcomes. To enable further 
understanding, we also collected information on the structures and 
processes – in particular the underlying CPs – in which the CPS was 
implemented. 
The Structure-Process-Outcome (SPO) model of Donabedian [24] 
posits that the quality of the structure of the organization in which care 
is provided impacts the quality of the processes, and that each of these 
two impacts the quality of the outcomes. ‘Structure’ refers firstly to 
structural characteristics of the organization in which the CPS is 
implemented, such as the type of hospital, the existing IT infrastructure 
and the organizational structure. It may more widely refer to the health 
system context, e.g. in relation to financing or integration with primary 
care. ‘Process’ firstly refers to the patient and provider (inter)actions 
which form the health service delivery. Obviously, this process may be 
importantly defined by a CP. ‘Outcome’ explains the effects of care on 
patient health as well as outcomes for other stakeholders, in particular 
staff. 
Through the lens of the SPO model, CPS implementation is an 
intervention in the information systems and hence in the structure of an 
organization. The objectives of this intervention are to improve the 
process of care (e.g. in terms of guideline adherence or costs) and sub-
sequently the outcomes for patients (e.g. mortality) and staff (e.g. user 
satisfaction). The first part of the results section synthesizes effects on 
processes and outcomes resulting from CPS implementation. These re-
sults are organized using the high level SPO model. Given the current 
lack of understanding and evidence on clinical pathway software 
effectiveness, no further predefined models on measurement – for 
instance on outcome categories – were imposed. Instead data collection 
and synthesis proceeded inductively: we firstly extracted data as 
completely as possible, and then synthesized and structured findings 
when possible. Throughout, the study and context specifics are explicitly 
analyzed and reported, to prevent study biases from implicitly impact-
ing synthesized results. Possible publication bias is addressed in the 
discussion section. 
The second part of the methods and results are devoted to advancing 
understanding of the mechanisms explaining the outcome effects. These 
mechanisms (M) are important as it is well known that the effects (or 
Outcomes (O)) of intervention (I) vary with the context (C) in which 
they are deployed. The conceptual model relating these constructs is 
acronymously known as the CIMO model [25,26]. For instance, the ef-
fect of introducing a CPS may importantly depend on the presence of a 
pre-existing paper-based CP. We therefore collected data in the form of 
hypothesized and evidenced mechanisms from the introduction, results, 
discussion and conclusion sections of the included articles and synthe-
sized the evidence on mechanisms found. This review is the first to 
explicitly consider pre-existing CPs as a contextual factor in the analysis. 
The Preferred Reporting Items for Systematic Reviews and Meta- 
Analyses checklist (PRISMA framework) was used as a guideline for 
the systematic review to ensure transparency and completeness of the 
report [27]. 
3. Results 
The searches resulted in 2904 articles. After removal of duplicate 
articles, and title and abstract screening, 65 of these remained for full- 
text review, 6 of which were from the studies in Neame et al. [20]. 
After full-text review, 12 articles were ultimately included [15,22, 
Table 1 
Exclusion criteria.  
Not a scientific peer reviewed journal paper (no conference papers, abstracts, posters, 
book chapters, no grey literature). 
Not in English. 
Not a primary study (e.g. systematic reviews). 
Not reporting outcomes (e.g. implementation studies). 
Intervention is not restricted to implementation of (Clinical Pathway and) Clinical 
Pathway Software (e.g. studies which include other concurrent quality 
improvement interventions, as is the case when software is used to measure effects 
of other interventions). 
Studies on software implementation for processes intentionally only covering part of 
‘the mutual decision making and organization of care processes for a well-defined 
group of patients during a well-defined period’ (e.g. implementation of a safety 
bundle or a surgery checklist).  
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28–37]. The reasons of exclusion are mentioned in Fig. 1. Inter-rater 
agreement was substantial with a Kappa of 0.66 (P = 0.009). 
The remainder of this section is organized as follows. First we 
describe reported results on processes for contexts with and without pre- 
existing pathways, and then on outcomes. Next we present results on 
mechanisms explaining the results for both contexts. 
3.1. Study characteristics 
Of the 12 included studies, six (50 %) [28–30,35–37] were published 
in 2015 or later, five (42 %) [15,31–34] from 2010 to 2014, and one 
(8%) [22] in 2006. From a geographical perspective, we found that six 
(50 %) were conducted in the United States [29,32,33,35–37], three (25 
%) in Europe (Germany, The Netherlands and Italy) [15,22,34], two (17 
%) in Asia (China and Korea) [28,31], and one (8%) in Canada [30]. The 
medical conditions considered range from diagnosis and treatment of 
acute conditions (stroke, pneumonia) to (end-stage) treatment of 
chronic conditions (heart failure, oncological conditions). Ten included 
hospitals were tertiary, university or teaching hospitals, one study was 
performed at oncological centers [35] and one study included a network 
of community and university hospitals [37]. Hence, there is consider-
able heterogeneity among the included studies, as also expressed in the 
number of cases/patients/participants which varies from 34 to 4700. 
There were also differences in the Hospital Information Systems 
already in place, the use of EMRs, other related software, and imple-
mentation approaches. Only one study (Schuld) [15] reported on 
implementation of a CPS within already available standard software. 
Four studies evaluated the introduction of software in a context where a 
(paper-based) CPs was already in place [15,28,30,34]. The remaining 
eight studied interventions which simultaneously introduced a CP and 
supporting software [22,29,31–33,35–37]. In the latter studies, it is 
difficult to separate the effects of introducing the CP from the effect of 
introducing the CPS – if at all desirable. Hence, there are essential dif-
ferences in the contexts and the interventions among the twelve studies 
(see Table 2). 
Below we present results following the SPO framework, while 
continuously bearing the heterogeneity in mind, in particular regarding 
pre-existing CPs. 
Ten (83 %) [22,28–34,36,37] articles used before-after comparison. 
The before measures were often acquired retrospectively instead of 
being collected for the purpose of the study. The other studies were a 
cohort study and a cross-sectional study [15,35]. None of the studies 
adopted a randomized design. 
There was also considerable heterogeneity among the research ob-
jectives and hence among the reported process and outcome indicators. 
Ten studies present quantitative results on process indicators (e.g. length 
of stay) [22,28–31,33–37]. Five report on patient outcomes (e.g. mor-
tality) [22,29,30,33,36]. One study presents quantitative results on 
patient satisfaction [34]. Three studies present quantitative results on 
user satisfaction [15,31,32] (see Table 3). Taken together, all these 
forms of heterogeneity prohibit meaningful aggregation of quantitative 
results other than categorizing them, and we report accordingly below. 
3.2. Evidence on process 
3.2.1. Adherence 
Seven studies report on the process indicator adherence. All of the 
five studies reporting from a context without pre-existing CP report 
adherence to be high(er) after CPS implementation, however not 
necessarily in full. Brignole et al. [22] report that guideline adherence 
increased. Wilde et al. [33] report that adherence in the form of 
appropriate antibiotic therapy and de-escalating from unnecessary 
medication improved when CPS use was mandatory, yet reduced again 
when changed to be voluntary. Katzan et al. [29] report that already 
high guideline adherence was not significantly affected by CPS imple-
mentation. Gebhardt et al. [37] found differences in adherence between 
community and university hospitals, where the latter shows signifi-
cantly more adherence improvement. Ellis et al. [35] simply report high 
Fig. 1. Article selection flow diagram.  
M. Askari et al.                                                                                                                                                                                                                                  
International Journal of Medical Informatics 147 (2021) 104374
4
Table 2 
Study characteristics of included articles. LOS = Length of Stay, a = Pre: mandatory use of CPS, Post: voluntary use of CPS.  
Author Country Study type Department / medical 
condition(s) / participants 




Jackman et al. 
2017 [36] 
USA Before-after Stage IV non–small-cell lung 
cancer 
370 (160 pre vs. 
210 post) 
Decrease in hospital charges after implementation of pathways; 
chemotherapy was the single largest contributor to these 
savings. Clinical outcomes remained consistent, with no 
significant difference in median overall survival. 
Ellis et al. 
2016 [35] 
USA Retrospective EMR 
review 
Breast cancer 643 Adherence rates for included patients are 92.6 %, 96.4 %, and 
87.5 % in the low-, intermediate-, and high-risk categories, 
respectively. 
Wang et al. 
2016 [28] 
China Before-after Breast carcinoma, cataract, 
inguinal hernia, Diabetes 
Mellitus type 2 
1773 (901 pre vs. 
872 post) 
After CPS implementation, the median total LOS decreased with 
1− 3 days. Total hospital costs decreased. 





Bone metastasis 12.678 treatment 
courses 
The overall rate of single-fraction treatment, as encouraged by 
the guideline, increased. 
Katzan et al. 
2015 [29] 
USA Before-after Stroke 1106 Significant reduction in inpatient mortality as well as LOS in 
patients with ischemic stroke, but not in the control patients 
with intracerebral hemorrhage or subarachnoid hemorrhage. 
O’Connell 
et al. 2015 
[30] 
Canada Before-after Head and neck free flap 
patients 
256 (99 pre vs. 
157 post) 
No significant difference in LOS. Rate of major complications 
was significantly higher in the pre-phase, no significant 
difference in rate of minor complications. 
Sung et al. 
2013 [31] 
Korea Before-after Supracondylar fracture of the 
humerus 
122 (90 pre vs. 32 
post) 
Decrease in LOS and hospital costs. Significant increase in the 
satisfaction score of doctors, but no change in satisfaction of 
nurses. 
Hyde et al. 
2012 [32] 
USA Before- after Medical-surgical department 34 Improvements in pathway documentation and staff satisfaction 
(regarding education patient, communicating patient 
information, documentation). 
Wilde et al. 
2012 [33] 
USA Before-after Intensive care units (medical, 
surgical, neurotrauma) 
136 (72 pre vs. 64 
post)a 
Proportion of patients with appropriate antibiotics within 24 h 
of diagnose was not significantly different when comparing 
mandatory use to voluntary use. Time to appropriate therapy 
was shorter for patients treated with CPS. Mortality was not 
significantly different. 
Schuld et al. 
2011 [15] 
Germany Retrospective survey Surgical department staff 4700 After CPS implementation, knowledge of the aims increased 
significantly under nursing staff, whereas doctor’s knowledge 
remained high. High satisfaction level on usability and 
graphical layout. Acceptability of CPS is independent from 
staff’s computer knowledge. 




Before-after Atrial fibrillation 600 Patient satisfaction rose significantly. Reduced walk-through 
times. Risk calculator and drug therapy recommendations were 
completed significantly better. 
Brignole et al. 
2006 [22] 
Italy Before-after Syncope 1674 (929 pre vs. 
745 post) 
Significantly lower hospitalization rate, shorter LOS, fewer tests 
performed per patient. The mean cost per patient and per 
diagnoses were significantly lower.  
Table 3 
Summary of process and outcome measures per study.  
Author Pre-existing 






















No Yes Yes  Yes Yes No   
Sung [31] No Yes Yes For some 
treatment steps 
Yes   For doctors  
Katzan [29] No Yes     Yes   
Wang [28] No Yes For some 
conditions  
Yes     
Hyde [33] Yes         
Schuld [15] Yes         
O’Connell 
[30] 
Yes No Yes   Yes    
Wilde [33] Yes No  For some 
treatments  
Yes Yes   
Valente 
[34] 
Yes   Yes  Yes   Yes 
Jackman 
[36] 
No  Yes    No   
Gebhardt 
[37] 
No     Yes    
Ellis [35] No     Yes (without 
control)     
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adherence after implementation without control. 
From contexts with pre-existing paper-based CPs, Valente et al. [34] 
report an improved adherence, mostly in relation to timeliness of 
treatment steps, and Wang et al. [28] report improved guideline 
adherence with regard to pre- and peri-operative processes and drugs 
prescription. 
3.2.2. Diagnostics 
All three studies (100 %) which considered effects on diagnostics, 
such as laboratory tests and radiology examinations [22,28,31], re-
ported a reduction in diagnostic testing in a context without pre-existing 
CP. These studies report the reduction to be related to improved 
adherence to guidelines in the pre-intervention situation and/or the 
avoidance of s unnecessary and inappropriate diagnostics. 
3.2.3. Length of stay 
Six studies examined whether the implementation of CPS led to a 
difference in total length of stay (LOS) in the hospital [22,28–31,33]. 
O’Connell et al. [30] and Wilde et al. [33], who report from contexts 
where a CP was already in place and the interventions consisted of 
transitioning from paper based to electronic, did not find a significant 
change in LOS. It may be noted that both these studies report on rela-
tively complex medical conditions. Wang et al. [28] found a significant 
decrease in LOS after the implementation of a CPS, as did the three 
studies [22,31,33] reporting from contexts in which no CP was imple-
mented a priori. Sung et al. [31] found that pre-operative LOS increased, 
but post-operative LOS did not. Wang et al. [28] report a significant 
decrease in both. 
3.2.4. Timeliness of care 
Two studies assessed effects on timeliness [33,34]. Valente et al. [34] 
found significant improvements in timeliness of care for a pre-existing 
CP which includes outpatient episodes. Wilde et al. [33] report that 
the time to appropriate therapy was shorter for ICU patients with 
ventilator associated pneumonia following the CP supported by the CPS. 
3.2.5. Costs 
Four studies assessed the impact CPS implementation had on total 
costs of hospitalization [22,28,31,36]. Brignole et al. [22], Sung et al. 
[31], Wang et al. [28] and Jackman et al. [36] report that the total costs 
decreased after the implementation of a CPS. According to Wang et al. 
[28], this result was especially due to the LOS reduction. Brignole et al. 
[22] state that the lower costs were due to the lower admissions caused 
by CPS use and 24 % reduction in tests. Sung et al. [31] also reported 
that the laboratory and radiologic costs decreased significantly, which 
indicates a reduction of unnecessary medical practice. However, they 
found cost of materials to have increased significantly. By contrast, 
Jackman et al. [36] did not find a significant effect on cost of di-
agnostics, radiology (and a variety of other categories), yet reported a 
significant reduction in treatment cost (antineoplastics, radiation ther-
apy). All of these studies regarded a context without pre-existing CP. 
Katzan et al. [29] are the only authors to mention the considerable in-
vestment required for the CPS development and implementation, 
without providing a specific amount. 
3.3. Evidence on outcomes 
3.3.1. Clinical and functional outcomes 
Of the four studies which considered mortality, three are from a 
context without pre-existing CP. One of these three [29] report a sig-
nificant decrease in mortality rate. The other two studies [22,36] found 
no significant effect. The fourth study [33] report a non-significant (P =
0.112) increase resulting from switching from mandatory to voluntary 
use of the CP(S), while mentioning that the mortality originally 
decreased significantly when the CPS was introduced. 
O’Connell et al. [30] report a significant reduction in major 
complications but not in minor complications from a context with 
pre-existing CP. Katzan et al. [29] found no significant effect on func-
tional outcomes such as activities of daily living (ADL) and physical 
activity in a context without pre-existing CP. 
3.3.2. Patient satisfaction & experience 
Valente et al. [34] reports an increase in patient satisfaction from 86 
% to 91 % in the implementation phase compared to the development 
phase of the CPS in a context in which a care program was already in 
place, without reporting significance. According to the patients, the 
improved scheduling culture and the information provided about the 
care process were the major areas of improvement since the imple-
mentation of the CPS. 
3.3.3. User satisfaction & experience 
Katzan et al. [29] report that the perceived workload concerning the 
electronic medical record decreased in a context without pre-existing 
CP. Schuld et al. [15] and Hyde [33] evaluate the introduction of a 
CPS in a context of a pre-existing CP and report that the administrative 
workload remains time consuming but was expected to go down, resp. 
that nurses were more likely to experience an increased workload than 
physicians. From a context without pre-existing CP, Sung et al. [31] 
report likewise that user satisfaction among physicians increased 
significantly, while it did not for nurses. They report process facilitation 
to be an important perceived user benefit. The most important benefits 
of CPS as perceived by users from contexts with pre-existing CPs are 
standardization [15], process facilitation [15,32], cost-effectiveness 
[15] and prompting patient education [32]. 
3.4. Mechanisms 
3.4.1. From structure to process to outcome 
The introductions and discussions of the included studies present a 
wide variety of mechanisms explaining the effects the CPS imple-
mentation may have on care processes and outcomes. For instance, Hyde 
et al. [32] mention that ‘automating the patient care plan can promote 
collaboration among healthcare disciplines…promote continuity of 
care…and ultimately the patient and family’. 
While all included studies refer to corresponding evidence when 
hypothesizing effects of CPS implementation, none appraise the validity 
of the evidence in their own context. Hence, the validity of proposed 
mechanisms remains unclear. Below we overview hypothesized mech-
anisms and synthesized indirect evidence. 
The findings of Katzan et al. [29] suggest that CPS may not further 
improve already high adherence resulting from previous CP imple-
mentation. Conversely, Brignole et al. [22] consider prior diagnosis and 
treatment haphazard and unstratified, and (therefore) did find signifi-
cant improvement in adherence. Like Gebhardt et al. [37] conclude that 
the existence of a guideline is not enough, because it may not be 
disseminated or implemented. Valente et al. [34] claim adherence 
improved because of the CPS implementation, which in their case 
involved provisioning of documents with guidelines and latest evidence. 
The relevance of context in the relationship between the CPS inter-
vention and the outcome adherence is illustrated by Gebhardt et al. [37], 
who found that the same CPS intervention that improved adherence 
significantly in academic hospitals, did not do so in community hospi-
tals. Wilde et al. [33] provide interesting insight into potential lack of 
subsequent effects of processes on outcomes when reporting that 
adherence is significantly and positively associated with proper medi-
cation (process) yet not significantly with mortality (outcome). 
Sung et al. [31] explore another commonly hypothesized mechanism 
regarding the care provided (process) and the corresponding cost. They 
relate a decrease in diagnostics and lab tests to a decrease in corre-
sponding costs and an increase in material use and costs. Their evidence 
on costs is not empirical as costs are derived from the process mea-
surements rather than being independently measured. O’Connell et al. 
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[30] report a reduction in major complications, which they propose to 
cause a reduction in LOS and subsequently of costs, without presenting 
data on LOS or costs. The cost reductions reported by Jackman et al. [36] 
are reductions in charges. 
On satisfaction with using the CPS, Sung et al. [31] report that the 
increase observed for physicians may be caused by the standardization 
the CPS implementation brought among a number of participating 
hospitals, making the systems easier to use for residents. This mecha-
nism does not apply to nurses, whose satisfaction did not increase. 
Hyde et al. [32] and Valente et al. [34] both propose that the CPS 
may cause an increase in patient satisfaction as it reduces duplication of 
patient data provisioning, resulting in more time for personalized care. 
3.4.2. Implementation 
A technological organizational intervention such as CPS imple-
mentation is complex and may easily fail to achieve its objectives. Hence 
the results obtained not only depend on the intervention and the 
context, but also on the implementation. Valente et al. [34] point at the 
importance of communication skills for the project leader. Hyde et al. 
[32] emphasize that leadership buy-in is essential and that continued 
collaboration with clinical ancillary staff was of importance for their 
understanding. They posit that piloting helps to garnish such buy-in and 
support. They also discuss how, alternatively, the CPS may become a 
‘nursing document’, instead of promoting integrated, patient-focused, 
multidisciplinary care. 
O’Connell et al. [30] consider the acceptance by physicians to be the 
biggest challenge which can be addressed through user friendliness and 
perceived usefulness. Likewise, Jackman et al. [36] propose that un-
friendly alerts may reduce adherence. They provide evidence that 
adherence improved when the software did not offer the option to 
deviate, or made deviations subject to peer review. Wilde et al. [33] find 
that adherence decreased when CPS use ceased to be mandatory and 
stewardship is undone. Lastly, Jackman et al. [36] conjecture that 
financial incentives may reduce effectiveness when adherence reduces 
provider income. 
Schuld et al. [15] consider a stepwise implementation approach 
which involves key users and a steering committee, frequent interper-
sonal feedback and staff education as success factors. Jackman et al. [36] 
stress the importance of active physician collaboration. Valente et al. 
[34] supplement this view stating that it is important to communicate, 
evaluate, and keep everyone updated, and to remain firmly rooted in 
daily practice. A complication of piloting and stepwise approaches is 
pointed out by Hyde et al. [32]. They report that simultaneous reliance 
on paper and electronic forms of documentation during pilots can 
interfere with staff communication and workflow. Valente et al. [34] 
propose engagement of nurses as a success factor. Schuld et al. [15] 
emphasize that all professional groups must be involved in the imple-
mentation process and find the impact of nurses on success to be much 
larger than assumed. 
4. Discussion 
This systematic review relies on 12 publications to assess the effec-
tiveness of clinical pathway software for inpatient treatment. The evi-
dence base can therefore be characterized as scarce and it includes 
studies from very different contexts and from over a decade of tech-
nology advancement. 
Ten of the included studies present results on process indicators: 
adherence, diagnostics, length of stay, timeliness, and costs [22,28–31, 
33–37]. Five studies report on patient outcomes: functional outcomes, 
clinical outcomes (such as mortality), and on patient/user satisfaction 
and experience [22,29,30,33,36]. None of the studies present direct 
evidence on mechanisms explaining how clinical pathway software 
implementation have produced these results within their various 
contexts. 
Five studies addressing effects on adherence report improvements 
[22,28,33,34,37]. The other two studies [29,35] report adherence to 
remain high after implementation. The improvements have been re-
ported to depend on the clinical pathway software use being mandatory 
and to vary between academic and community hospitals. 
Some authors propose that the access to and dissemination of 
guidelines and the latest evidence clinical pathway software provides, as 
well as transparency on adoption, positively impacted acceptance and 
adherence among physicians. Such findings however are just beginning 
to address the mechanisms explaining how clinical pathway software 
might impact adherence and by whom. 
Adherence improvement is subsequently mentioned as a mechanism 
to drive further process improvement, as supported by evidenced on all 
process indicators which have been reported. Three studies reporting 
effects on diagnostics found reductions in diagnostic testing which 
closely relate to improved adherence [22,28,31]. Four studies reporting 
from a context in which no prior clinical pathway was implemented 
found a length of stay reduction [22,28,29,31], whereas the two studies 
reporting from a context with a pre-existing pathway did not find a 
significant effect [30,33]. The two studies reporting on timeliness of care 
also both report improvements [33,34]. 
The evidence on cost reduction is weak as the cost reductions pre-
sented are obtained via mechanistic reasoning. Moreover, none of the 
studies report on actual cost of clinical pathway software implementa-
tion. The importance of cost-effectiveness in today’s healthcare warrants 
further research into costs effects and cost of software and 
implementation. 
Effects on health outcome indicators regard the clinical outcomes 
mortality, major complications, minor complications, and the functional 
outcomes ADL and physical activities. Mortality is reported by four 
studies [22,29,33,36], only one of which found a significant improve-
ment [29]. As improvement of health outcomes is often an important 
goal of clinical pathway software adoption, more and stronger evidence 
on health effects is called for, including the relevant mechanisms which 
explain how differences in software and context relate to outcomes 
obtained. 
Evidence on patient and user experience is also scarce. Our synthesis 
may provide initial evidence that physicians experience clinical 
pathway software to be more beneficial than nurses, perhaps explained 
by a workload mechanism: nurses are more likely to end up with 
administrative burden increases [21]. 
Lastly, several authors make claims about the importance of the 
clinical pathway software implementation project being properly led 
and managed as a mechanism to explain achieving desired outcomes. 
The adopted research designs cannot produce evidence on these matters. 
For now the relevance of leadership styles, communication, engaging 
physicians and others, and taking a stepwise approach remain topics for 
further research. 
Our study has some limitations: although our search was extensive 
and considered references checks, we may still have missed articles. 
Weakness of research designs of included studies forms a limitation that 
was also observed in a previous review with a broader pathway defini-
tion and technology scope [20]. Our narrowing of the scope enabled 
more specific and conclusive findings which distinguish between con-
texts with and without pre-existing clinical pathways. While our search 
identified additional literature, the resulting evidence base is small. The 
heterogeneity of the studies prohibited quantitative synthesis (e.g., in 
the form of meta-analysis). Lastly, it is likely that reported studies are 
biased towards successful implementations. 
5. Conclusion 
Our study provides evidence that a primary effect of clinical pathway 
software is to increase adherence towards higher levels. Increased 
adherence in turn positively impacts other process indicators such as 
length of stay, timeliness of care, and diagnostic effectiveness. Effects on 
costs remain unclear. Evidence on subsequent effects of process 
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improvements on outcomes for patients, physicians and nurses is 
inconclusive and calls for further research on mechanisms explaining 
how process effects relate to outcome effects. Likewise, the evidence- 
base on (mechanisms explaining how) implementation project charac-
teristics relate to effects on process and outcome indicators is very scarce 
and needs development to promote effective implementation. 
Summary Table 
What was already known on the topic?  
a Software-based clinical pathways increase in popularity and are 
known to lead to several benefits in the hospital environment such as 
enhancing the efficiency on the work floor and providing better 
overview of tasks.  
b Insufficient research has been conducted on the effectiveness of 
software-based CPs in inpatient settings.  
c There is no understanding of the corresponding mechanisms that 
explain (lack of) effectiveness of clinical pathway software 
implementation. 
What this study added to our knowledge  
a Our study provides evidence that clinical pathway software increases 
adherence and improves other process indicators such as length of 
stay, timeliness of care, and diagnostic effectiveness. 
b Evidence on subsequent effects of process improvements on out-
comes for patients, physicians and nurses is inconclusive. 
c The evidence-base on (mechanisms explaining how) CPS imple-
mentation project characteristics relate to effects on process and 
outcome indicators is very scarce. 
Author contribution 
MA and JVDK designed the study. All the authors gathered the data. 
MA and JVDK drafted the paper. All authors revised the paper critically, 
and helped interpreting the results. 
Transparency document 
The Transparency document associated with this article can be found 
in the online version. 
Declaration of Competing Interest 
The authors report no declarations of interest. 
Appendix A. Supplementary data 
Supplementary material related to this article can be found, in the 
online version, at doi:https://doi.org/10.1016/j.ijmedinf.2020.104374. 
References 
[1] WHO, Patient Safety: Making Health Care Safer [Available from:, World Health 
Organization, Geneva, 2018 https://www.who.int/patientsafety/publications/pa 
tient-safety-making-health-care-safer/en/. 
[2] H. Campbell, R. Hotchkiss, N. Bradshaw, M. Porteous, Integrated care pathways, 
BMJ 316 (7125) (1998) 133–137. 
[3] I. Scott, What are the most effective strategies for improving quality and safety of 
health care? Intern. Med. J. 39 (6) (2009) 389–400. 
[4] M.C. Meulendijk, M.R. Spruit, F. Willeboordse, M.E. Numans, S. Brinkkemper, 
W. Knol, et al., Efficiency of clinical decision support systems improves with 
experience, J. Med. Syst. 40 (4) (2016) 76. 
[5] K. VanHaecht, M. Panella, R. van Zelm, W. Sermeus, An overview on the history 
and concept of care pathways as complex interventions, J. Integr. Care Pathw. 14 
(3) (2010) 117–123. 
[6] R.J. Coffey, J.S. Richards, C.S. Remmert, S.S. LeRoy, R.R. Schoville, P.J. Baldwin, 
An introduction to critical paths, Qual. Manage. Health Care 1 (1) (1992) 45–54. 
[7] T. Rotter, L. Kinsman, E. James, A. Machotta, H. Gothe, J. Willis, et al., Clinical 
pathways: effects on professional practice, patient outcomes, length of stay and 
hospital costs, Cochrane Database Syst. Rev. (3) (2010), CD006632. 
[8] K. VanHaecht, M. Bollmann, K. Bower, C. Gallagher, A. Gardini, J. Guezo, 
Prevalence and use of clinical pathways in 23 countries - an international survey by 
the European Pathway Association, J. Integr. Care Pathw. 10 (1) (2006) 28–34. 
[9] L. Kinsman, T. Rotter, E. James, P. Snow, J. Willis, What is a clinical pathway? 
Development of a definition to inform the debate, BMC Med. 8 (2010) 31. 
[10] K. Vanhaecht, K. De Witte, M. Panella, W. Sermeus, Do pathways lead to better 
organized care processes? J. Eval. Clin. Pract. 15 (5) (2009) 782–788. 
[11] D. Allen, E. Gillen, L. Rixson, The effectiveness of integrated care pathways for 
adults and children in health care settings: a systematic review, JBI Libr. Syst. Rev. 
7 (3) (2009) 80–129. 
[12] M.F. Aarnoutse, S. Brinkkemper, M. de Mul, M. Askari, Pros and cons of clinical 
pathway software management: a qualitative study, Stud. Health Technol. Inform. 
247 (2018) 526–530. 
[13] C. Fernandez-Llatas, T. Meneu, J.M. Benedi, V. Traver, Activity-based process 
mining for clinical pathways computer aided design, Conf. Proc. IEEE Eng. Med. 
Biol. Soc. 2010 (2010) 6178–6181. 
[14] W. Li, K. Liu, H. Yang, C. Yu, Integrated clinical pathway management for medical 
quality improvement - based on a semiotically inspired systrems architecture, Eur. 
J. Inf. Syst. 23 (4) (2014) 400–417. 
[15] J. Schuld, T. Schafer, S. Nickel, P. Jacob, M.K. Schilling, S. Richter, Impact of IT- 
supported clinical pathways on medical staff satisfaction. A prospective 
longitudinal cohort study, Int. J. Med. Inform. 80 (3) (2011) 151–156. 
[16] U. Ronellenfitsch, E. Rossner, J. Jakob, S. Post, P. Hohenberger, M. Schwarzbach, 
Clinical Pathways in surgery: should we introduce them into clinical routine? A 
review article, Langenbecks Arch. Surg. 393 (4) (2008) 449–457. 
[17] R. Lenz, R. Blaser, M. Beyer, O. Heger, C. Biber, M. Baumlein, et al., IT support for 
clinical pathways–lessons learned, Int. J. Med. Inform. 76 (Suppl 3) (2007) 
S397–402. 
[18] J. Varghese, M. Kleine, Si Gessner, S. Sandmann, M. Dugas, Effects of computerized 
decision support system implementations on patient outcomes in inpatient care: a 
systematic review, J. Am. Med. Inform. Assoc. 25 (5) (2018) 593–602. 
[19] B. Knols, M. Louws, A. Hardenbol, J. Dehmeshki, M. Askari, The usability aspects 
of medication-related decision support systems in the inpatient setting: a 
systematic review, Health Inform. J. (2019), 1460458219841167. 
[20] M.T. Neame, J. Chacko, A.E. Surace, I.P. Sinha, D.B. Hawcutt, A systematic review 
of the effects of implementing clinical pathways supported by health information 
technologies, J. Am. Med. Inform. Assoc. 26 (4) (2019) 356–363. 
[21] M. Askari, J. Tam, M.F. Aarnoutse, M. Meulendijk, Perceived effectiveness of 
clinical pathway software: a before-after study in the Netherlands, Int. J. Med. 
Inform. 135 (2019), 104052. 
[22] M. Brignole, A. Ungar, A. Bartoletti, I. Ponassi, A. Lagi, C. Mussi, et al., 
Standardized-care pathway vs. Usual management of syncope patients presenting 
as emergencies at general hospitals, Europace. 8 (8) (2006) 644–650. 
[23] M.L. McHugh, Interrater reliability: the kappa statistic, Biochem. Med. (Zagreb) 22 
(3) (2012) 276–282. 
[24] A. Donabedian, The quality of care. How can it be assessed? JAMA 260 (12) (1988) 
1743–1748. 
[25] D. Denyer, D. Ttranfield, J.E. van Aken, Developing design propositions through 
research synthesis, Organ. Stud. 29 (3) (2008) 393–413. 
[26] R. Pawson, N. Tiley, Realistic Evaluation, 1 ed., Sage, London, 1997. 
[27] A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, et al., 
The PRISMA statement for reporting systematic reviews and meta-analyses of 
studies that evaluate healthcare interventions: explanation and elaboration, BMJ 
339 (2009) b2700. 
[28] S. Wang, X. Zhu, X. Zhao, Y. Lu, Z. Yang, X. Qian, et al., DRUGS system improving 
the effects of clinical pathways: a systematic study, J. Med. Syst. 40 (3) (2016) 59. 
[29] I.L. Katzan, Y. Fan, M. Speck, J. Morton, L. Fromwiller, J. Urchek, et al., Electronic 
stroke CarePath: integrated approach to stroke care, Circ. Cardiovasc. Qual. 
Outcomes 8 (6 Suppl 3) (2015) S179–89. 
[30] D.A. O’Connell, B. Barber, M.F. Klein, J. Soparlo, H. Al-Marzouki, J.R. Harris, et al., 
Algorithm based patient care protocol to optimize patient care and inpatient stay in 
head and neck free flap patients, J. Otolaryngol. Head Neck Surg. 44 (2015) 45. 
[31] K. Sung, C. Chung, K. Lee, S. Lee, S. Ahn, S. Park, et al., Application of clinical 
pathway using electronic medical record system in pediatric patients with 
supracondylar fracture of the humerus: a before and after comparative study, BMC 
Med. Inform. Decis. Mak. 13 (2013) 87. 
[32] E. Hyde, B. Murphy, Computerized clinical pathways (care plans): piloting a 
strategy to enhance quality patient care, Clin. Nurse Spec. 26 (5) (2012) 277–282. 
[33] A.M. Wilde, M.D. Nailor, D.P. Nicolau, J.L. Kuti, Inappropriate antibiotic use due to 
decreased compliance with a ventilator-associated pneumonia computerized 
clinical pathway: implications for continuing education and prospective feedback, 
Pharmacotherapy 32 (8) (2012) 755–763. 
[34] M. Valente, E. Zwaan, M. Wit, G.P. Kimman, V. Umans, Effects of a digital clinical 
pathway for elective electrocardioversion for atrial fibrillation on quality of care, 
Crit. Pathw. Cardiol. 9 (4) (2010) 207–211. 
[35] P.G. Ellis, A.M. Brufsky, S. Beriwal, K.G. Lokay, H.O. Benson, S.B. McCutcheon, et 
al., Pathways clinical decision support for appropriate use of key biomarkers, 
J. Oncol. Pract. 12 (6) (2016) e681–7. 
[36] D.M. Jackman, Y. Zhang, C. Dalby, T. Nguyen, J. Nagle, C.A. Lydon, et al., Cost and 
survival analysis before and after implementation of dana-farber clinical pathways 
for patients with stage IV non-small-cell lung cancer, J. Oncol. Pract. 13 (4) (2017) 
e346-e52. 
[37] B.J. Gebhardt, M.S. Rajagopalan, B.S. Gill, D.E. Heron, S.M. Rakfal, J.C. Flickinger, 
et al., Impact of dynamic changes to a bone metastases pathway in a large, 
integrated, National Cancer Institute-designated comprehensive cancer center 
network, Pract. Radiat. Oncol. 5 (6) (2015) 398–405. 
M. Askari et al.                                                                                                                                                                                                                                  
